Can You Get High From CBD? A Scientific Review - Mustaf Medical
Understanding CBD and Its Effects on the Body
As the wellness landscape in 2026 shifts towards personalized nutrition, preventative health, and healthy aging, many individuals are seeking a deeper, science-backed understanding of the supplements they incorporate into their routines. Cannabidiol, or CBD, a compound found in the cannabis plant, has gained significant attention for its potential wellness applications. However, a primary question for many is whether it produces the same intoxicating "high" as its well-known cousin, tetrahydrocannabinol (THC). A growing body of scientific evidence provides a clear answer, demonstrating that the effects of CBD are fundamentally different from those of THC. This article will explore the scientific and clinical insights into why CBD does not cause a high, how it works in the body, and what the research says about its safety and various forms. It is important to note that evidence and effects can vary among individuals, and brand names mentioned are for research context only.
Background on Cannabidiol (CBD)
Cannabidiol (CBD) is one of over a hundred chemical compounds known as cannabinoids found in the Cannabis sativa plant. Unlike THC, which is the primary psychoactive compound in marijuana that produces a "high," CBD is non-intoxicating. CBD can be derived from both marijuana and hemp plants. However, under the 2018 Farm Bill, legal hemp-derived CBD products must contain less than 0.3% THC, a trace amount that is not sufficient to cause psychoactive effects. This legal distinction is crucial, as the source of the CBD determines its THC content and legal status. The interest in CBD from both the public and scientific communities is largely due to its potential therapeutic applications without the intoxicating effects associated with marijuana.
The Science and Mechanism of CBD
The primary reason CBD does not produce a "high" is its unique interaction with the body's endocannabinoid system (ECS). The ECS is a complex cell-signaling system that plays a role in regulating a range of functions and processes, including sleep, mood, appetite, and memory. It consists of endocannabinoids (cannabinoids produced by the body), receptors, and enzymes. The two primary cannabinoid receptors are CB1 and CB2.
THC produces its psychoactive effects by binding directly with and activating CB1 receptors, which are highly concentrated in the brain and central nervous system. This activation triggers the euphoria and other sensory alterations associated with being high. In stark contrast, CBD has a very low affinity for CB1 receptors. Instead of activating them, CBD is known to act as a negative allosteric modulator of the CB1 receptor. This means it can change the shape of the CB1 receptor, which in turn weakens THC's ability to bind to it and can actually reduce the intoxicating effects of THC.
CBD's influence extends beyond just the cannabinoid receptors. Research indicates it interacts with several other receptor systems in the body, which may contribute to its observed effects. For instance, CBD has been shown to interact with:
* Serotonin Receptors: At high concentrations, CBD can directly activate the 5-HT1A serotonin receptor, which may play a role in its potential anti-anxiety effects.
* TRPV1 Receptors: CBD can activate and then desensitize these receptors, which are involved in regulating pain, inflammation, and body temperature.
* GABA-A Receptors: CBD can enhance the effects of GABA, the main inhibitory neurotransmitter in the brain, which contributes to a calming effect.
Furthermore, CBD can influence the ECS indirectly by inhibiting the FAAH (fatty acid amide hydrolase) enzyme. This enzyme is responsible for breaking down anandamide, an endocannabinoid often referred to as the "bliss molecule." By inhibiting FAAH, CBD can increase the levels of anandamide in the brain's synapses, which may contribute to mood enhancement and stress reduction.
When consumed orally in forms like CBD gummies or oils, CBD has a relatively low bioavailability, estimated to be between 6% and 19%, due to extensive first-pass metabolism in the liver. It is metabolized by cytochrome P450 enzymes, primarily CYP3A4 and CYP2C19. This interaction with liver enzymes is also why CBD can potentially interact with other medications. The half-life of CBD is estimated to be between 18 to 32 hours.
Comparative Context of CBD Administration
The method of consuming CBD significantly impacts its absorption, the time it takes to feel effects, and its overall bioavailability. Understanding these differences can help inform individuals about what to expect from various product types.
| Form | Bioavailability | Time to Peak Concentration | Considerations |
|---|---|---|---|
| Oral (Edibles, Capsules) | 6% - 19% | 1 - 6 hours | Slow onset of effects, but longer duration. Subject to first-pass metabolism, which reduces bioavailability. |
| Sublingual (Tinctures) | Higher than oral (variable) | Faster than oral | Bypasses the digestive system for more direct absorption into the bloodstream through membranes under the tongue. |
| Inhalation (Vaping) | 11% - 45% (mean 31%) | Within minutes | Rapid onset of effects, but shorter duration. May not be suitable for all individuals. |
| Topical (Creams, Lotions) | Low / Localized | N/A | Does not typically enter the bloodstream. Effects are localized to the area of application. |
Safety and Side Effects
While CBD is generally well-tolerated, it can cause side effects for some individuals. According to the Mayo Clinic and other health organizations, potential side effects include:
* Dry mouth
* Diarrhea
* Reduced appetite
* Drowsiness and fatigue
* Changes in mood
The U.S. Food and Drug Administration (FDA) has approved one CBD-based drug, Epidiolex, for the treatment of certain rare seizure disorders. Clinical trials for this drug have shown that high doses of CBD can be associated with elevated liver enzymes, a potential sign of liver damage.
Additionally, because CBD is metabolized by cytochrome P450 enzymes, it can interact with other medications. This can either increase or decrease the effects of other drugs, so it's important to consult with a healthcare professional before using CBD, especially if you are taking other medications.
Frequently Asked Questions (FAQ)
1. Why does THC get you high but CBD doesn't?
THC gets you high by directly binding to and activating the CB1 receptors in the brain. CBD does not bind effectively to CB1 receptors and can even block THC from binding, which is why it doesn't produce an intoxicating effect.
2. Can you fail a drug test from using CBD?
Pure CBD will not cause you to fail a drug test that is screening for THC. However, some CBD products, particularly those that are full-spectrum or poorly regulated, may contain trace amounts of THC that could accumulate in the body and potentially lead to a positive test result with frequent use.
3. Is CBD psychoactive?
While CBD is not intoxicating, it is considered psychoactive because it can affect the brain and may influence mood and perception, for example, by reducing anxiety. However, it does not produce the euphoria or altered state associated with a "high."
4. What are the common side effects of CBD?
Common side effects of CBD are generally mild and can include drowsiness, dry mouth, diarrhea, and reduced appetite.
5. Is it possible for a CBD product to contain THC?
Yes. Full-spectrum CBD products are designed to contain a range of cannabinoids, including up to 0.3% THC. Additionally, due to a lack of consistent regulation in the industry, some products may be mislabeled and contain more THC than advertised.
This content is for informational purposes only. Always consult a healthcare professional before starting any supplement.